Ana Aleman
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
- Transplantation top 10%
- Renal Transplantation Outcomes and Treatments
Papers in
-
- Multiple Myeloma Research and Treatments 8
- Chronic Myeloid Leukemia Treatments 1
-
- Cancer therapeutics and mechanisms 2
- Protein Degradation and Inhibitors 1
- Co-authors
- Sergio Giralt (14 shared papers)Richard E. Champlin (9 shared papers)Donna Weber (9 shared papers)Charles S. Cleeland (3 shared papers)Michèle L. Donato (3 shared papers)Rima M. Saliba (5 shared papers)Chitra Hosing (3 shared papers)J. Neumann (1 shared paper)
- Journals
- Blood (4 papers)Cancer (3 papers)Seminars in Oncology (2 papers)Biology of Blood and Marrow Transplantation (2 papers)Journal of Pain and Symptom Management (1 paper)
- Partner nations
- United States
In The Last Decade
Ana Aleman
15 papers receiving 346 citations
Peers
Comparison fields: 5 of 52
- Hematology 190
- Transplantation 26
- Oncology 126
- Genetics 26
- Immunology 48
Countries citing papers authored by Ana Aleman
This map shows the geographic impact of Ana Aleman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Aleman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Aleman more than expected).
Fields of papers citing papers by Ana Aleman
This network shows the impact of papers produced by Ana Aleman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Aleman. The network helps show where Ana Aleman may publish in the future.
Co-authors
The 25 scholars most cited alongside Ana Aleman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 85 | |
| 2 | 2006 | 51 | |
| 3 | 2007 | 51 | |
| 4 | 2004 | 46 | |
| 5 | 2008 | 33 | |
| 6 | 2003 | 20 | |
| 7 | 2007 | 18 | |
| 8 | 2001 | 13 | |
| 9 | 2003 | 12 | |
| 10 | 2006 | 6 | |
| 11 | 2004 | 5 | |
| 12 | 2004 | 4 | |
| 13 | 2005 | 4 | |
| 14 | 2005 | 1 | |
| 15 | 2005 | 1 |
About Ana Aleman
Ana Aleman is a scholar working on Hematology, Molecular Biology, Oncology, Immunology and Surgery, having authored 15 papers that have together received 350 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (8 papers), Cancer therapeutics and mechanisms (2 papers), Cancer Treatment and Pharmacology (2 papers), Bone health and treatments (2 papers), Chronic Myeloid Leukemia Treatments (1 paper), Protein Degradation and Inhibitors (1 paper), Immunodeficiency and Autoimmune Disorders (1 paper) and Lymphoma Diagnosis and Treatment (1 paper). The work is most often cited by research in Hematology (190 citations), Transplantation (26 citations), Oncology (126 citations), Genetics (26 citations) and Immunology (48 citations). Ana Aleman has collaborated with scholars based in United States. Frequent co-authors include Sergio Giralt, Richard E. Champlin, Donna Weber, Charles S. Cleeland, Michèle L. Donato, Rima M. Saliba, Chitra Hosing, J. Neumann, Tito R. Mendoza and Raymond Alexanian. Their work appears in journals such as Blood, Cancer, Seminars in Oncology, Biology of Blood and Marrow Transplantation and Journal of Pain and Symptom Management.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.